Safety and Efficacy of Autologous Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients—the DIADEM Study from the Chronic Malignancies Working Party of the EBMT

Investigators reported on the outcomes of 110 patients, median age 57 years, who had become dialysis-dependent pre-autologous stem cell transplantation (ASCT) and who underwent a first ASCT.